AbbVie Inc won US antitrust approval for its acquisition of Botox makerย Allergan Plc, clearing the last hurdle from competition regulators to the $63 billion deal.
The Federal Trade Commissionย said late Tuesday that it signed off on the takeover after the companies agreed to resolve competition concerns by selling two products toย Nestle SA and transferring toย AstraZeneca Plc the rights to a treatment for Crohnโs disease thatโs in development.